PubTransformer

A site to transform Pubmed publications into these bibliographic reference formats: ADS, BibTeX, EndNote, ISI used by the Web of Knowledge, RIS, MEDLINE, Microsoft's Word 2007 XML.




PMID- 28505632
OWN - NLM
STAT- MEDLINE
DA  - 20170515
DCOM- 20170808
LR  - 20170808
IS  - 1539-3704 (Electronic)
IS  - 0003-4819 (Linking)
VI  - 167
IP  - 2
DP  - 2017 Jul 18
TI  - Missed Opportunities for Measles, Mumps, Rubella Vaccination Among Departing U.S.
      Adult Travelers Receiving Pretravel Health Consultations.
PG  - 77-84
LID - 10.7326/M16-2249 [doi]
AB  - Background: Measles outbreaks continue to occur in the United States and are
      mostly due to infections in returning travelers. Objective: To describe how
      providers assessed the measles immunity status of departing U.S. adult travelers 
      seeking pretravel consultation and to assess reasons given for nonvaccination
      among those considered eligible to receive the measles, mumps, rubella (MMR)
      vaccine. Design: Observational study in U.S. pretravel clinics. Setting: 24 sites
      associated with Global TravEpiNet (GTEN), a Centers for Disease Control and
      Prevention-funded consortium. Patients: Adults (born in or after 1957) attending 
      pretravel consultations at GTEN sites (2009 to 2014). Measurements: Structured
      questionnaire completed by traveler and provider during pretravel consultation.
      Results: 40 810 adult travelers were included; providers considered 6612 (16%) to
      be eligible for MMR vaccine at the time of pretravel consultation. Of the
      MMR-eligible, 3477 (53%) were not vaccinated at the visit; of these, 1689 (48%)
      were not vaccinated because of traveler refusal, 966 (28%) because of provider
      decision, and 822 (24%) because of health systems barriers. Most MMR-eligible
      travelers who were not vaccinated were evaluated in the South (2262 travelers
      [65%]) or at nonacademic centers (1777 travelers [51%]). Nonvaccination due to
      traveler refusal was most frequent in the South (1432 travelers [63%]) and in
      nonacademic centers (1178 travelers [66%]). Limitation: These estimates could
      underrepresent the opportunities for MMR vaccination because providers accepted
      verbal histories of disease and vaccination as evidence of immunity. Conclusion: 
      Of U.S. adult travelers who presented for pretravel consultation at GTEN sites,
      16% met criteria for MMR vaccination according to the provider's assessment, but 
      fewer than half of these travelers were vaccinated. An increase in MMR
      vaccination of eligible U.S. adult travelers could reduce the likelihood of
      importation and transmission of measles virus. Primary Funding Source: Centers
      for Disease Control and Prevention, National Institutes of Health, and the Steve 
      and Deborah Gorlin MGH Research Scholars Award.
FAU - Hyle, Emily P
AU  - Hyle EP
AD  - From Massachusetts General Hospital, Harvard Medical School, and Boston
      University, Boston, Massachusetts; Centers for Disease Control and Prevention,
      Atlanta, Georgia; Bronx Lebanon Hospital Center, Bronx, New York; and Icahn
      School of Medicine at Mount Sinai, New York, New York.
FAU - Rao, Sowmya R
AU  - Rao SR
AD  - From Massachusetts General Hospital, Harvard Medical School, and Boston
      University, Boston, Massachusetts; Centers for Disease Control and Prevention,
      Atlanta, Georgia; Bronx Lebanon Hospital Center, Bronx, New York; and Icahn
      School of Medicine at Mount Sinai, New York, New York.
FAU - Jentes, Emily S
AU  - Jentes ES
AD  - From Massachusetts General Hospital, Harvard Medical School, and Boston
      University, Boston, Massachusetts; Centers for Disease Control and Prevention,
      Atlanta, Georgia; Bronx Lebanon Hospital Center, Bronx, New York; and Icahn
      School of Medicine at Mount Sinai, New York, New York.
FAU - Parker Fiebelkorn, Amy
AU  - Parker Fiebelkorn A
AD  - From Massachusetts General Hospital, Harvard Medical School, and Boston
      University, Boston, Massachusetts; Centers for Disease Control and Prevention,
      Atlanta, Georgia; Bronx Lebanon Hospital Center, Bronx, New York; and Icahn
      School of Medicine at Mount Sinai, New York, New York.
FAU - Hagmann, Stefan H F
AU  - Hagmann SHF
AD  - From Massachusetts General Hospital, Harvard Medical School, and Boston
      University, Boston, Massachusetts; Centers for Disease Control and Prevention,
      Atlanta, Georgia; Bronx Lebanon Hospital Center, Bronx, New York; and Icahn
      School of Medicine at Mount Sinai, New York, New York.
FAU - Taylor Walker, Allison
AU  - Taylor Walker A
AD  - From Massachusetts General Hospital, Harvard Medical School, and Boston
      University, Boston, Massachusetts; Centers for Disease Control and Prevention,
      Atlanta, Georgia; Bronx Lebanon Hospital Center, Bronx, New York; and Icahn
      School of Medicine at Mount Sinai, New York, New York.
FAU - Walensky, Rochelle P
AU  - Walensky RP
AD  - From Massachusetts General Hospital, Harvard Medical School, and Boston
      University, Boston, Massachusetts; Centers for Disease Control and Prevention,
      Atlanta, Georgia; Bronx Lebanon Hospital Center, Bronx, New York; and Icahn
      School of Medicine at Mount Sinai, New York, New York.
FAU - Ryan, Edward T
AU  - Ryan ET
AD  - From Massachusetts General Hospital, Harvard Medical School, and Boston
      University, Boston, Massachusetts; Centers for Disease Control and Prevention,
      Atlanta, Georgia; Bronx Lebanon Hospital Center, Bronx, New York; and Icahn
      School of Medicine at Mount Sinai, New York, New York.
FAU - LaRocque, Regina C
AU  - LaRocque RC
AD  - From Massachusetts General Hospital, Harvard Medical School, and Boston
      University, Boston, Massachusetts; Centers for Disease Control and Prevention,
      Atlanta, Georgia; Bronx Lebanon Hospital Center, Bronx, New York; and Icahn
      School of Medicine at Mount Sinai, New York, New York.
LA  - eng
GR  - K01 HL123349/HL/NHLBI NIH HHS/United States
GR  - U01 CK000175/CK/NCEZID CDC HHS/United States
GR  - U19 CI000514/CI/NCPDCID CDC HHS/United States
PT  - Editorial
PT  - Multicenter Study
PT  - Observational Study
DEP - 20170516
PL  - United States
TA  - Ann Intern Med
JT  - Annals of internal medicine
JID - 0372351
RN  - 0 (Measles-Mumps-Rubella Vaccine)
SB  - AIM
SB  - IM
MH  - Adult
MH  - Disease Outbreaks/prevention & control
MH  - Female
MH  - Humans
MH  - Male
MH  - Measles/epidemiology/*prevention & control
MH  - *Measles-Mumps-Rubella Vaccine
MH  - Mumps/epidemiology/*prevention & control
MH  - Referral and Consultation
MH  - Rubella/epidemiology/*prevention & control
MH  - *Travel
MH  - Treatment Refusal
MH  - United States/epidemiology
MH  - Vaccination/*statistics & numerical data
PMC - PMC5513758
MID - NIHMS863941
EDAT- 2017/05/16 06:00
MHDA- 2017/08/09 06:00
CRDT- 2017/05/16 06:00
PMCR- 2018/07/18
AID - 2626466 [pii]
AID - 10.7326/M16-2249 [doi]
PST - ppublish
SO  - Ann Intern Med. 2017 Jul 18;167(2):77-84. doi: 10.7326/M16-2249. Epub 2017 May
      16.